Status:
UNKNOWN
Evaluation of the Detection of Atrial Fibrillation by a Wearable Dynamic ECG Recorder
Lead Sponsor:
Huami Corporation
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
A Randomized, Crossover Trial is conducted to Evaluate Consistency Atrial fibrillation diagnosis between the Wearable Dynamic ECG Recorder and the Control device. In this investigation, the following...
Eligibility Criteria
Inclusion
- \- All study participants must be able to provide written informed consent prior to study procedure. This study has 2 Phases.
- Phase 1:
- Health conscious individuals
- \> 18 years of age
- Phase 2:
- \> 18 years of age
- non critical patients ever diagnosed with atrial fibrillation
Exclusion
- • \< 18 years old
- Unable to consent
- Phase 1:
- \> 80 years of age
- Previous history of cardiac disease (e.g., atrial fibrillation, myocardial infarction, congestive heart failure)
- current status of non-sinus heart rhythm
- Phase 2:
- \- Critical patients
Key Trial Info
Start Date :
April 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04462653
Start Date
April 24 2020
End Date
September 1 2020
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Chest hospital
Shanghai, China